• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2

tetano

Editor, Senior Moderator
PLoS Pathog


. 2023 May 17;19(5):e1011123.
doi: 10.1371/journal.ppat.1011123. Online ahead of print. Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2

Yong Ma[SUP] 1 [/SUP], Pengbin Li[SUP] 1 [/SUP], Yunqi Hu[SUP] 1 [/SUP], Tianyi Qiu[SUP] 2 [/SUP], Lixiang Wang[SUP] 3 [/SUP], Hongjie Lu[SUP] 1 [/SUP], Kexin Lv[SUP] 1 [/SUP], Mengxin Xu[SUP] 1 [/SUP], Jiaxin Zhuang[SUP] 4 [/SUP], Xue Liu[SUP] 4 [/SUP], Suhua He[SUP] 5 [/SUP], Bing He[SUP] 1 [/SUP], Shuning Liu[SUP] 1 [/SUP], Lin Liu[SUP] 1 [/SUP], Yuanyuan Wang[SUP] 1 [/SUP], Xinyu Yue[SUP] 1 [/SUP], Yanmei Zhai[SUP] 1 [/SUP], Wanyu Luo[SUP] 1 [/SUP], Haoting Mai[SUP] 1 [/SUP], Yu Kuang[SUP] 1 [/SUP], Shifeng Chen[SUP] 6 [/SUP], Feng Ye[SUP] 6 [/SUP], Na Zhou[SUP] 6 [/SUP], Wenjing Zhao[SUP] 4 [/SUP], Jun Chen[SUP] 3 [/SUP], Shoudeng Chen[SUP] 5 [/SUP], Xiaoli Xiong[SUP] 7 [/SUP], Mang Shi[SUP] 4 [/SUP], Ji-An Pan[SUP] 4 [/SUP], Yao-Qing Chen[SUP] 1 8 [/SUP]



Affiliations
Abstract

SARS-CoV Spike (S) protein shares considerable homology with SARS-CoV-2 S, especially in the conserved S2 subunit (S2). S protein mediates coronavirus receptor binding and membrane fusion, and the latter activity can greatly influence coronavirus infection. We observed that SARS-CoV S is less effective in inducing membrane fusion compared with SARS-CoV-2 S. We identify that S813T mutation is sufficient in S2 interfering with the cleavage of SARS-CoV-2 S by TMPRSS2, reducing spike fusogenicity and pseudoparticle entry. Conversely, the mutation of T813S in SARS-CoV S increased fusion ability and viral replication. Our data suggested that residue 813 in the S was critical for the proteolytic activation, and the change from threonine to Serine at 813 position might be an evolutionary feature adopted by SARS-2-related viruses. This finding deepened the understanding of Spike fusogenicity and could provide a new perspective for exploring Sarbecovirus' evolution.


 
Back
Top Bottom